BMC Cardiovascular Disorders (Nov 2024)

Prognostic value of the diagnosis of anemia in patients with heart failure: an analysis based on the Colombian heart failure registry (RECOLFACA)

  • Fernán Mendoza-Beltrán,
  • Luis Eduardo Echeverría,
  • Alex Rivera-Toquica,
  • Hugo Ernesto Osorio-Carmona,
  • Alejandro Posada-Bastidas,
  • Juan Camilo García,
  • Alejandro David Ochoa-Morón,
  • Balkis Rolong,
  • Fernando Manzur-Jatin,
  • José Ignacio Mosquera-Jiménez,
  • Oscar Alfredo Pacheco-Jiménez,
  • Álvaro Hernán Rodríguez-Cerón,
  • Patricia Rodríguez-Gómez,
  • Clara Saldarriaga,
  • Juan Esteban Gómez-Mesa

DOI
https://doi.org/10.1186/s12872-024-04291-2
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Background Anemia represents a commonly reported comorbidity in patients diagnosed with heart failure (HF), related with a higher risk of unfavorable outcomes such as recurrent hospitalizations and mortality. There is a lack of evidence in Latin America regarding this topic. Our aim was to evaluate the prognostic value of the diagnosis of anemia in patients from the Colombian Heart Failure Registry (RECOLFACA). Methods RECOLFACA registry included adult ambulatory patients with HF in 60 medical centers in Colombia during 2017–2019. Baseline characteristics of patients diagnosed with anemia and those without anemia were compared. The main outcome was all-cause mortality. A Cox proportional hazards regression model was used to evaluate the factors linked to the main outcome in patients with anemia. A statistically significant p-value was < 0.05. Results From the 2528 patients included in RECOLFACA, 2409 had at least one available hemoglobin value, and 726 (30.1%) corresponded to a diagnosis of anemia. Patients with anemia were significantly older, and had a higher prevalence of comorbidities, especially hypertension, type 2 diabetes, and chronic kidney disease (CKD). Patients without anemia had significantly lower mortality rate of 0.30 per 1000 person-years (95% CI 0.26–0.35), compared to patients diagnosed with anemia who had a mortality rate of 0.42 per 1000 person-years (95% CI 0.26–0.98) (p < 0.001). Lastly, the multivariate model results showed that the presence of an anemia diagnosis was associated with a significantly greater risk of mortality (HR 1.48; 95% CI 1.06, 2.05, p < 0.001). Conclusions Anemia represents a highly prevalent comorbidity in patients with HF in Colombia and is also related with higher mortality in ambulatory patients during follow-up period. Our results highlight the relevance of anemia in the pathophysiology of HF. Nevertheless, due to its observational nature, out study results must be validated and further explored in future studies to elucidate the potential underlying mechanisms of this association. Graphical Abstract

Keywords